Pfizer on Monday unveiled its slate of executives who will run the combined company after it closes its roughly $150 billion inversion deal to buy Allergan.
Edwards Lifesciences raised its full-year earnings forecast, anticipating stronger sales of its artificial heart valves.
Dow component Pfizer reported an adjusted 4Q profit of $0.53 per share, topping the estimate for $0.52. Revenue for the drugmaker came in at $14 billion, also beating the estimate for $13.56 billion.
Theranos Inc.'s main retail partner is suspending some ties to the blood-testing laboratory in the wake of a critical regulatory inspection report.
So much for controlling medical costs.
Eli Lilly reported an adjusted 4Q profit of $0.78 per share, matching the estimate. Revenue for the drugmaker came in at $5.38 billion, beating the estimate for $5.3 billion.
FNC Medical A-Team's Dr. Manny Alvarez on mounting concerns about the Zika Virus.
Johnson & Johnson forecast 2016 sales below analysts' estimate and reported a 2.4 percent drop in sales for the fourth quarter, hurt by a strong dollar.
NYU School of Medicine's Dr. Devi E. Nampiaparampil on mounting concerns over the Zika Virus.
Fox News Health Medical A-Team's Dr. David Samadi on efforts to find a cure for cancer.
Johnson & Johnson said it would cut up to 6% of its workforce in its medical-devices division as part of an effort to cut $1 billion in annual costs.
War veteran and cancer patient Brad Giesting and his wife Annie share their experience with using an experimental drug to beat cancer.
FNC Medical A-Team's Dr. Marc Siegel on efforts to find a cure for cancer.
Rick Stollmeyer sits down with FOXBusiness.com's Jade Scipioni.
Chef Rocco DiSpirito trades celebrity for weight loss crusade.
Valeant Pharmaceuticals is planning to appoint a new chief executive while its CEO remains under hospital care, said people familiar with the matter.
William Ackman's Pershing Square Capital Management LP trimmed its stake in Valeant Pharmaceuticals International Inc. to 8.5%, a move the hedge fund said was related to year-end tax planning.
KaloBios Pharmaceuticals Inc said on Wednesday that it had been notified by Nasdaq that its stock would be delisted using the exchange operator's "discretionary" authority.
The U.S. government signed up 8.2 million people for health insurance through the HealthCare.gov website, including 2.1 million people from the insurers' most sought-after demographic - those aged under 35, the top health official said on Tuesday.
The average price of healthcare premiums under the Affordable Care Act, or Obamacare, will rise by an average of 12.56% nationally in 2016, according to new data released this week by the Robert Wood Johnson Foundation.